- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
- Pregnancy Safe For Women With Myasthenia Gravis, Study Concludes
A sleep medicine doctor reports on his entirely unsatisfactory experiences with Synapse Health, UnitedHealthcare's PBM for CPAPs:
Insurance Middlemen Are a Nightmare for My Sleep Patients
By Jan Kriska - January 9, 2026Nearly every day, exhausted patients walk into my office desperate for relief from sleep apnea. The condition, which causes people to stop breathing in their sleep, is surprisingly common and can be life-threatening. Thankfully, it's also manageable with the right equipment.
In fact, the hardest part of providing care and solutions for my patients suffering from sleep apnea isn't the condition itself. It's fighting the insurance middlemen who routinely delay and deny the equipment hundreds of my patients need to stay alive.
One of the worst offenders is Synapse Health, a company tapped by UnitedHealthcare to provide durable medical equipment to its Medicare Advantage beneficiaries in twelve states across the South and Midwest. Since the partnership began, patients have faced unacceptable delays in getting the equipment they urgently need -- delays so severe that they amount to malpractice.
It's time for UnitedHealthcare to wake up and take responsibility for Synapse's failures. That means ending its partnership entirely -- or, at the very least, demanding immediate improvements to the company's operations so patients can once again breathe easy.
Synapse acts as an intermediary between health plans, medical equipment suppliers, providers, and patients, overseeing the "entire [durable medical equipment] experience -- from prescription to delivery." It promises simplified ordering, transparency and coordination of orders, efficient processing, and "unmatched" customer service.
But in my experience, it hasn't delivered anything close.
Consider the issues surrounding the continuous positive airway pressure, or CPAP, machines commonly used to help treat sleep apnea. CPAP machines keep patients' airways open and deliver oxygen while they sleep -- a life-saving necessity for many of my patients. Yet thanks to Synapse, getting one of these gold-standard machines has become a logistical nightmare.
The problems begin with Synapse's online portal, which is faulty and extraordinarily difficult to navigate. The company bombards patients and providers with requests for documentation, often for information we've already submitted, and frequently claims it never received portal submissions altogether. There's no way to edit medical equipment orders within the portal, so we have to manually reenter the order time when we must change something.
The portal has a chat feature, but we almost never receive responses when we use it to ask questions. When we do speak with a Synapse representative, they don't know how to use the portal, either.
Worse, the company routinely cancels orders without notice when information is missing, leaving providers and patients in the dark until equipment deliveries are long overdue. When Synapse denies a CPAP machine for one of my patients, it provides no guidance on how to appeal or obtain an alternative treatment. By not explaining how to challenge a denial, Synapse hinders patients' right to appeal under the Affordable Care Act.
Before Synapse took over, my patients could get a CPAP machine in a few weeks. Now, it routinely takes more than a month -- and sometimes up to three. One desperate patient posted on Reddit -- yes, there's a Reddit thread about Synapse -- that they resorted to purchasing their medical equipment on eBay.
Previously, many of my patients would have simply called their medical equipment supplier to check on the status of their machine. But Synapse forbids suppliers from talking directly to patients. All communication must go through Synapse -- and getting in touch with someone can prove incredibly difficult.
Patients have reported not being able to get a representative on the phone. I haven't had much luck either. More than once, a Synapse representative has said a supervisor would get back to me. I'm still waiting.
For physicians, jumping through these hoops is maddening. For patients, it could be deadly. In a sleep study that followed more than 1,500 participants over 18 years, about one in five people who had sleep apnea but weren't controlling it with a CPAP machine died. Even over the short term, patients who don't use a CPAP experience spikes in blood sugar, heart rate, blood pressure, and stress hormones.
While patients suffer, both Synapse and UnitedHealthcare profit. Under their capitated arrangement, Synapse receives a fixed amount of money per patient per month, creating a clear incentive to delay or deny equipment. UnitedHealthcare also benefits by spending less on care -- all while shifting the blame to Synapse.
Under its agreement with UnitedHealthcare, Synapse originally covered 480,000 patients in Georgia and North Carolina. But that number recently grew. As of August 1, UnitedHealthcare expanded Synapse's reach to cover another 300,000 Medicare Advantage patients in Alabama, South Carolina, Tennessee, and Virginia. Then, on October 1, the program expanded to another 330,000 patients across Illinois, Indiana, Kentucky, Michigan, Ohio, and West Virginia.
Synapse must make the necessary changes to live up to its promises. If it doesn't, UnitedHealthcare must cut ties. My patients deserve to sleep safe and sound -- not suffocate at the hands of insurance middlemen.
Dr. Jan Kriska is a board-certified physician in internal medicine, sleep medicine, and lipidology with over 30 years of clinical experience. He is the owner of Kriska Health, PLLC, operating three sleep medicine clinics in North Carolina, and a former senior partner at Blue Ridge Cardiology and Internal Medicine.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















